ProteoGenix names Durlin Hickok, M.D., MPH, Senior Vice President & Chief Medical Officer

COSTA MESA, CA, October 15, 2007---ProteoGenix announced today that it has named Durlin Hickok, M.D., MPH, Senior Vice President and Chief Medical Officer.

Dr. Hickok previously served as Senior Vice President at Adeza Biomedical and part of a management team that successfully developed the fetal fibronectin test for prediction of preterm birth. Dr. Hickok joined ProteoGenix following an initial public offering and subsequent acquisition by Cytyc Corporation. Dr. Hickok practiced clinical Maternal-Fetal Medicine for 18 years prior to joining Adeza Biomedical. While in clinical practice, he served in a variety of capacities including Chief of the Department of Obstetrics and Gynecology at Virginia Mason Medical Center in Seattle, Washington. Dr. Hickok has more than 80 publications on topics including preterm delivery, preeclampsia and other aspects of pregnancy care and testing. Dr. Hickok’s residency and fellowship training were at the University of Washington, Department of Obstetrics and Gynecology, where he also received a Masters Degree in Public Health through the Robert Wood Johnson Clinical Scholars Program.